TaiMed Biologics Inc. (4147) Stock Price & Analysis
4147 Stock Chart & Stats
- Day’s Range
- TWD 49.65 - TWD 55.50
- 52-Week Range
- TWD 47.00 - TWD 75.40
- Previous Close
- TWD 55.10
- Volume
- N/A
- Average Volume (3M)
- 631.63K
- Market Cap
- TWD 15.03B
- Enterprise Value
- TWD 12.85B
- Total Cash (Recent Filing)
- TWD 1.61B
- Total Debt (Recent Filing)
- TWD 478.14M
- Price to Earnings (P/E)
- ―
- Beta
- 0.30
- Next Earnings
- Nov 18, 2026 (Est.)
- EPS Estimate
- -0.29
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
4147 FAQ
What was TaiMed Biologics Inc.’s price range in the past 12 months?
What is TaiMed Biologics Inc.’s market cap?
When is TaiMed Biologics Inc.’s upcoming earnings report date?
How were TaiMed Biologics Inc.’s earnings last quarter?
Is TaiMed Biologics Inc. overvalued?
Does TaiMed Biologics Inc. pay dividends?
What is TaiMed Biologics Inc.’s EPS estimate?
How many shares outstanding does TaiMed Biologics Inc. have?
What happened to TaiMed Biologics Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of TaiMed Biologics Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
TaiMed Biologics Inc.
TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases. The company develops and markets Trogarzo IV infusion and Trogarzo IV push, a monoclonal antibody for HIV treatment. It is also developing TMB-365, a monoclonal antibody used for HIV treatment and prevention which has completed a phase-1 clinical trial; and TMB-365 and TMB-380 combination, a monoclonal antibody combination therapy for HIV that is in phase-1b/2a clinical trial, as well as antibody-drug conjugates for cancer treatment. In addition, the company offers contract development and manufacturing services. It has a research and development agreement with Genentech and Biogen Inc. for Trogarzo TMB-355; and authorizes Samsung Biologics to produce TMB-355. TaiMed Biologics Inc. was incorporated in 2007 and is headquartered in Taipei, Taiwan.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Chin-Ming Chang
- Employees
- 799
- Website
- www.taimedbiologics.com
- Address
- NO. 607, Ruiguang Rd., Taipei, TP, 11492, TW
TaiMed Biologics Inc. (4147) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 4 | 14 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 0 | 0 | 12 |

